A Study to Investigate Efficacy and Safety of a TCA108 in Participants 18 Years With Uncontrolled Hypertension

Status:
NOT_YET_RECRUITING

Trial end date:
2029-09-01

Target enrollment:

Participant gender:

The purpose of this study if to evaluate the efficacy and safety of TCA108 in the treatment of hypertension.

PHASE3

EMS